Quantcast

North America

First Japanese company joins CARB-X partnership in the fight against drug resistant bacteria

CARB-X is partnering with Shionogi of Osaka, Japan, to support the development of a novel β-lactam antibiotic with potent activity

Posted in Asia, news, North America | Tagged , , | Leave a comment

Hikma launches Ritonavir Tablets USP

Hikma Pharmaceuticals’s wholly owned US subsidiary West-Ward Pharmaceuticals, has launched Ritonavir Tablets USP, 100 mg, the first AB-rated generic to

Posted in Approval, news, North America | Tagged , , | Leave a comment

BMS welcomes new Board member

Bristol-Myers Squibb’s Board of Directors has elected José Baselga, M.D., Ph.D., to the Board, effective March 1, 2018. Dr. Baselga will

Posted in news, North America | Tagged | Leave a comment

Novo Nordisk files for regulatory approval in the US and the EU for treatment of haemophilia A

Novo Nordisk has submitted a Biologics License Applications (BLA) to the US Food and Drug Administration (FDA) and a Marketing

Posted in Approval, Europe, news, North America | Tagged , , | Leave a comment

FDA rejects Celgene’s NDA for multiple sclerosis treatment

Celgene Corporation (NASDAQ:CELG) has received a Refusal to File letter from the United States Food and Drug Administration (FDA) regarding its New Drug

Posted in Approval, news, North America | Tagged , | Leave a comment

Lillys breast cancer drug gets additional FDA approval

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s (NYSE: LLY) Verzenio (abemaciclib) in combination with an aromatase

Posted in Approval, news, North America, studies | Leave a comment

FDA accepts sNDA filing for Allergan’s pneumonia drug

The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Allergan’s Avycaz (ceftazidime and avibactam) for priority review.

Posted in Approval, news, North America, Regions | Tagged , , , , | Leave a comment

Eli Lilly in leadership chances

Eli Lilly has made certain leadership changes, promoting several experienced Lilly leaders to executive roles, effective in 2018.

Posted in news, North America, Regions | Tagged , | Leave a comment

FDA OK’s Eli Lilly’s breast cancer drug

The U.S. Food and Drug Administration has approved  Eli Lilly’s Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed after taking therapy that alters a patient’s hormones (endocrine therapy).

Posted in Approval, news, North America, Regions | Tagged , , | Leave a comment

Novartis and UC Berkeley collaborate to tackle ‘undruggable’ disease targets

Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in cancer and other illnesses that have eluded traditional small-molecule compounds and are considered “undruggable.”

Posted in Europe, news, North America, studies | Tagged , , , , | Leave a comment